Close

Analyst Ratings for Del Mar Pharma (DMPI)

DMPI Rating Summary

  |   Expand Research on DMPI
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 10 / 10
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
9/6/2019 Maxim Group Jason McCarthy New Coverage Buy
(N/A)
2.00
(N/A)
0.61
(1.34)
119.67% Details
1/5/2017 Aegis Capital N/A New Coverage Buy
(N/A)
16.00
(N/A)
3.23
(1.34)
-58.51% Details